Strategies for clinical management of MRSA in the community; summary of an experts' meeting convened by the Centers for Disease Control and Prevention
Published Date:March 2006
Corporate Authors:Centers for Disease Control and Prevention (U.S.)
Methicillin-Resistant Staphylococcus Aureus
Prevention & Control
Community-Acquired Infections/Drug Therapy
Staphylococcal Infections/Drug Therapy
Staphylococcal Infections/Prevention & Control
Staphylococcus Aureus/Drug Effects
Description:Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a cause of skin infections and, less commonly, invasive infections among otherwise healthy adults and children in the community. More data are needed in order to fully understand the epidemiology, microbiology, and pathophysiology of these infections and to identify optimal prevention and treatment strategies. This report summarizes strategies for the clinical management of MRSA in the community based on discussions held at an MRSA experts’ meeting convened by the Centers for Disease Control and Prevention in July 2004, in conjunction with additional data available as of January 2006.
Suggested citation: Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA, and Participants in the CDC-Convened Experts’ Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community: Summary of an experts’ meeting convened by the Centers for Disease Control and Prevention. 2006. Available at http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html.
Supporting Files:No Additional Files
You May Also Like: